Y-Intercept (HK)’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,369
Closed -$51.5K 1536
2023
Q1
$51.5K Buy
+11,369
New +$51.5K 0.01% 1100